Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series B | Alive

About 1747

1747, with headquarters in San Francisco, is a leader in direct-to-participant clinical trials conducted directly with participants by means of the Internet. 1747 founders have decades of experience in teaching research methodology and conducting standard clinical trials for industry and the National Institute for Health. 1747's first trial, KALM, efficiently compared two nutraceuticals, Kava and Valerian, versus placebo for anxiety and insomnia.

1747 Headquarters Location

2565 Third St Unit 320

San Francisco, California, 94107,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing 1747

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

1747 is included in 2 Expert Collections, including Sleep Health & Wellness.


Sleep Health & Wellness

801 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.


Clinical Trials Tech

364 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

  • Where is 1747's headquarters?

    1747's headquarters is located at 2565 Third St, San Francisco.

  • What is 1747's latest funding round?

    1747's latest funding round is Series B.

  • Who are the investors of 1747?

    Investors of 1747 include Lilly Ventures and Sears Capital Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.